Respiralogics is a provider of innovative products for hospital, home and specialty care. We provide unique products that provide clinical efficacy, simplicity of operation and cost-effective solutions with specific emphasis on wound care. Freeing you to focus on patient care. The strong clinical background of our staff and business partners serve you well in presentation of new concepts for delivery of patient care, examination of needs and justification through the value analysis process. Most important, we are there to assist during product training and implementation. Visit our booth for a presentation on reduction in tracheostoma pressure injury with Respiragel Stoma Pad and the Ories Cohesive bandage for easy application and securement of soft bandage without need for scissors in your tiniest of infants.
NeXtGen Biologics Inc.
NeXtGenTM Biologics Inc. is a medical device company which owns a suite of patents encompassing extracellular matrix (ECM) platform technology derived from the Axolotl, an amphibian known for its regenerative properties. Leveraging a world-class team with expertise in medical devices and breakthrough tissue technologies, the company expects to offer physicians advanced platform solutions designed to treat and manage a myriad of complex conditions seen in wounds, general surgery, trauma, plastic surgery, cardiovascular diseases, neurosurgery, orthopedics and ophthalmology.
LifeNet Health
LifeNet Health provides transplantation and cellular solutions for healthcare providers and scientific researchers, to give healing every advantage for millions of patients around the world. Our full line of allograft biologic implants provide surgeons with the tools they need to improve the lives of these patients.
BioStem Technologies
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies – providing products that give clinicians, and their patients, access to solutions that deliver unmatched integrity for advanced wound care.
Aroa Biosurgery, Inc.
Aroa Biosurgery was founded in 2008 and is headquartered in Auckland, New Zealand. AROA is a soft-tissue regeneration company with a range of products for complex wounds and soft tissue reconstruction. The portfolio spans all sites of care, and is based on AROA ECM technology – derived from sheep forestomach. The AROA Portfolio: Endoform™ Natural, Endoform™ Antimicrobial, Myrad Matrix™, Myriad Morcells™, Myriad Morcells Fine™ and Symphony™